Treatment of non-small cell lung cancer

被引：0

作者：

Reinmuth, N. ^{[2
]}

Heigener, D. ^{[1
]}

Reck, M. ^{[1
]}

机构：

[1] Krankenhaus Grosshansdorf, Onkol Schwerpunkt, D-22927 Grosshansdorf, Germany

[2] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany

来源：

INTERNIST | 2011年 / 52卷 / 12期

关键词：

NSCLC; Chemotherapy; Anti-EGFR substances; Biomarkers; Angiogenesis; CLASSIFICATION; CHEMOTHERAPY; THERAPY;

D O I：

10.1007/s00108-011-2925-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Within recent years, the treatment of non-small cell lung cancer has become increasingly heterogeneous and complex. New cytotoxic agents and drugs against molecular targets have been developed. Moreover, new indications for therapy such as maintenance therapy have been explored. In addition, by assessing defined molecular markers, it is possible to identify patients who may likely respond to a given treatment. This approach will continue in the future; thus, it will be possible to characterize patient into subgroups based on molecular, histological, or clinical markers. This review will summarize the current state of the art in the treatment of non-small cell lung cancer.

引用

页码：1414 / 1421

页数：8

共 24 条

[1]

[Anonymous], J CLIN ONCOL

[2] Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non-Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10 [J].

Butts, Charles A. ;

Ding, Keyue ;

Seymour, Lesley ;

Twumasi-Ankrah, Philip ;

Graham, Barbara ;

Gandara, David ;

Johnson, David H. ;

Kesler, Kenneth A. ;

Green, Mark ;

Vincent, Mark ;

Cormier, Yvon ;

Goss, Glenwood ;

Findlay, Brian ;

Johnston, Michael ;

Tsao, Ming-Sound ;

Shepherd, Frances A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :29-34

[3] Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB NSCLC: CALGB 9633. [J].

Capelletti, M. ;

Wang, X. F. ;

Gu, L. ;

Graziano, S. L. ;

Kratzke, R. A. ;

Strauss, G. M. ;

Maddaus, M. ;

Green, M. R. ;

Vokes, E. E. ;

Janne, P. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[4]

Ettinger D S, 1996, Oncology (Williston Park), V10, P81

[5] Evolving Treatment Algorithms for Advanced Non-Small-Cell Lung Cancer: 2009 Looking Toward 2012 [J].

Gandara, David R. ;

Mack, Philip C. ;

Li, Tianhong ;

Lara, Primo N., Jr. ;

Herbst, Roy S. .

CLINICAL LUNG CANCER, 2009, 10 (06) :392-394

[6]

Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837

[7] Novel Therapeutic Targets in Non-small Cell Lung Cancer [J].

Janku, Filip ;

Garrido-Laguna, Ignacio ;

Petruzelka, Lubos B. ;

Stewart, David J. ;

Kurzrock, Razelle .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) :1601-1612

[8] Diagnostic evaluation of lung cancer [J].

Kreuter, M. ;

Herth, F. J. F. ;

Eberhardt, R. .

PNEUMOLOGE, 2008, 5 (03) :187-196

[9] Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].

Kwak, Eunice L. ;

Bang, Yung-Jue ;

Camidge, D. Ross ;

Shaw, Alice T. ;

Solomon, Benjamin ;

Maki, Robert G. ;

Ou, Sai-Hong I. ;

Dezube, Bruce J. ;

Jaenne, Pasi A. ;

Costa, Daniel B. ;

Varella-Garcia, Marileila ;

Kim, Woo-Ho ;

Lynch, Thomas J. ;

Fidias, Panos ;

Stubbs, Hannah ;

Engelman, Jeffrey A. ;

Sequist, Lecia V. ;

Tan, WeiWei ;

Gandhi, Leena ;

Mino-Kenudson, Mari ;

Wei, Greg C. ;

Shreeve, S. Martin ;

Ratain, Mark J. ;

Settleman, Jeffrey ;

Christensen, James G. ;

Haber, Daniel A. ;

Wilner, Keith ;

Salgia, Ravi ;

Shapiro, Geoffrey I. ;

Clark, Jeffrey W. ;

Iafrate, A. John .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703

[10] Maintenance Therapy in Nonsmall-Cell Lung Cancer A New Treatment Paradigm [J].

Mok, Tony S. K. ;

Ramalingam, Suresh S. .

CANCER, 2009, 115 (22) :5143-5154

← 1 2 3 →